EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma

Andrew C Kidd, Gordon W Cowell, Geoffrey A Martin, Jenny Ferguson, Dean A Fennell, Matt Evison, Kevin G Blyth

Cancer Treatment and Research Communications · 2024

DOI: 10.1016/j.ctarc.2024.100856 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Treatment and Research Communications, 2024. Verfasst von Andrew C Kidd und 6 weiteren Autor:innen. Beteiligte Einrichtung: Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK. Hauptthemen laut MEDLINE: Sarcopenia, Pleural Neoplasms, Mesothelioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Altered body composition is associated with adverse survival in multiple cancers. We determined the prevalence, prognostic significance and clinicopathological correlates of sarcopenia and adipopenia in Pleural Mesothelioma (PM) patients receiving chemotherapy. METHODS: We performed a multi-centre retrospective cohort study. Clinical data and CT images were retrieved for 111 patients from 4 UK centres. Skeletal muscle (at L3 and T4) and fat tissue areas (at L3 only) were measured on pre- and post-chemotherapy CT scans (ImageJ software) and normalised for height. Pre-chemotherapy sarcopenia and adipopenia were defined using validated thresholds, where available or indices

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaPleural NeoplasmsMesotheliomaHumansMaleFemaleAgedRetrospective StudiesPrognosisMiddle AgedPrevalenceBody CompositionMesothelioma, MalignantMuscle, SkeletalAged, 80 and overTomography, X-Ray Computed

Stichwörter der Autor:innen

AdipopeniaCachexiaMesotheliomaSarcopeniaSurvival

Autor:innen und Institutionen

  • Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK.
  • School of Cancer Sciences, University of Glasgow, UK; Department of Radiology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.
  • University of Leicester, UK.
  • Wythenshawe Hospital, Manchester, UK; Manchester Academic Health Science Centre (MAHSC), Faculty of Biology, Medicine & Health, University of Manchester, UK.
  • Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk.

Förderung

  • British Lung Foundation

Zitieren

APA

Kidd, A. C., Cowell, G. W., Martin, G. A., Ferguson, J., Fennell, D. A., Evison, M., & Blyth, K. G. (2024). The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2024.100856

Vancouver

Kidd AC, Cowell GW, Martin GA, Ferguson J, Fennell DA, Evison M, et al. The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma. Cancer Treatment and Research Communications. 2024. doi:10.1016/j.ctarc.2024.100856

BibTeX
@article{Kidd2024,
  author = {Kidd, Andrew C and Cowell, Gordon W and Martin, Geoffrey A and Ferguson, Jenny and Fennell, Dean A and Evison, Matt and Blyth, Kevin G},
  title = {The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma},
  journal = {Cancer Treatment and Research Communications},
  year = {2024},
  doi = {10.1016/j.ctarc.2024.100856}
}
Kostenlos starten →